Testing the Model: A Phase 1/2 Randomized Double Blind Placebo Control Trial of Targeted Therapeutics: Liposomal Glutathione and Curcumin
Technical Report,30 Sep 2015,29 Sep 2016
Nova Southeastern University Fort Lauderdale United States
Pagination or Media Count:
We propose to perform a phase III study comparing two nutraceuticals and placebo that target mediators identified in our prior dynamic modeling study of Gulf War Illness GWI. We will repeat the dynamic modeling before treatment and on therapy to assess our modeling and the impact of the interventions on the homeostatic networks we have identified, with an added focus on the glutathioneredox system.
- Medicine and Medical Research